VYCOVycor Medical, Inc.

About Vycor Medical, Inc. (VYCO)

Vycor Medical, Inc. (VYCO) is a Medical Devices company headquartered in Boca Raton, FL, United States whose shares trade over-the-counter on the OTCQB tier.

Vycor is dedicated to providing the medical community with innovative and superior surgical and therapeutic solutions and has a growing portfolio of FDA cleared or registered medical solutions that are changing and improving lives every day. The Company operates two business units: Vycor Medical and NovaVision, both of which adopt a minimally or non-invasive approach.

Products and services

Vycor Medical’s FDA-cleared ViewSite™ Brain Access System (VBAS) a minimally invasive neurosurgical device designed to improve access to brain lesions while reducing tissue damage and enhancing patient outcomes. The VBAS system has been approved and used in over 300 hospitals in the US and in numerous countries internationally. VBAS is protected by 46 issued and 11 pending patents and has been validated through 43 peer-reviewed studies. These studies demonstrate: less brain tissue damage; less invasive procedure; improved access and better visibility; and reduced operating and recovery time. NovaVision provides a suite of clinically supported vision rehabilitation therapies to help patients recover from visual impairments caused by stroke or other brain injury. The Visual Restoration Therapy (VRT) is the only commercialized FDA-cleared therapy for this type of vision rehabilitation, making it a unique and important option for patients seeking to regain lost visual capabilities. The complementary NeuroEyeCoach program, clinically supported by a 296-patient study (the largest to date in the neuro visual space), enables dramatic improvements in patients’ ability to detect objects in the visual field by training them to make better eye movements with improvement in over 80% of patients. The NovaVision therapies, while showing a positive impact on these patients’ lives, still require significant development to allow them to successfully address their market potential

VYCO key facts

Ticker symbol

VYCO

Market tier

OTCQB

Sector

Healthcare

Industry

Medical Devices

Headquarters

Boca Raton, FL, United States

Country of incorporation

US

Year of incorporation

2005

Employees

7

Estimated market cap

$2.27M (as of Apr 16, 2025)

Shares outstanding

33,424,464

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Vycor Medical, Inc. leadership

• Adrian Christopher Liddell — CEO
• Peter C. Zachariou — CEO, Vice President, Head of IR
• David Marc Cantor — President, IR

Explore more: Medical Devices stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with V